GT Biopharma, Inc.

The current price of GTBP is 3.65 USD — it has decreased by 3.95% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GT Biopharma, Inc. stocks are traded under the ticker GTBP.

GT Biopharma, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.

GTBP stock is 4.11% volatile and has beta coefficient of 1.67. Check out the list of the most volatile stocks — is GT Biopharma, Inc. there?

GTBP earnings for the last quarter are −1.65 USD per share, whereas the estimation was −3.00 USD resulting in a 44.98% surprise. The estimated earnings for the next quarter are −2.55 USD per share. See more details about GT Biopharma, Inc. earnings.

Yes, you can track GT Biopharma, Inc. financials in yearly and quarterly reports right on TradingView.

GTBP net income for the last quarter is ‪−2.96 M‬ USD, while the quarter before that showed ‪−2.42 M‬ USD of net income which accounts for −22.60% change. Track more GT Biopharma, Inc. financial stats to get the full picture.

Today GT Biopharma, Inc. has the market capitalization of ‪5.25 M‬, it has decreased by 2.86% over the last week.

No, GTBP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, GTBP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GT Biopharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.

GTBP reached its all-time high on Mar 28, 2016 with the price of 146818.04 USD, and its all-time low was 3.52 USD and was reached on Feb 14, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 2.00 employees. See our rating of the largest employees — is GT Biopharma, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GT Biopharma, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GT Biopharma, Inc. stock shows the sell signal. See more of GT Biopharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.